<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatr Rep</journal-id><journal-id journal-id-type="iso-abbrev">Pediatr Rep</journal-id><journal-id journal-id-type="publisher-id">pediatrrep</journal-id><journal-title-group><journal-title>Pediatric Reports</journal-title></journal-title-group><issn pub-type="ppub">2036-749X</issn><issn pub-type="epub">2036-7503</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407581</article-id><article-id pub-id-type="pmc">PMC12101304</article-id>
<article-id pub-id-type="doi">10.3390/pediatric17030056</article-id><article-id pub-id-type="publisher-id">pediatrrep-17-00056</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Exploring Partners, Parenting and Pregnancy Thinking in Late Adolescents and Young Adults with Inherited Metabolic Disorders</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8823-8061</contrib-id><name><surname>Tummolo</surname><given-names>Albina</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-pediatrrep-17-00056" ref-type="aff">1</xref><xref rid="c1-pediatrrep-17-00056" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Paterno</surname><given-names>Giulia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-pediatrrep-17-00056" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Carella</surname><given-names>Rosa</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-pediatrrep-17-00056" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2592-8767</contrib-id><name><surname>Melpignano</surname><given-names>Livio</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af2-pediatrrep-17-00056" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>De Giovanni</surname><given-names>Donatella</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-pediatrrep-17-00056" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Aric&#x000f2;</surname><given-names>Maurizio</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pediatrrep-17-00056"><label>1</label>Department of Metabolic Diseases, Clinical Genetics and Diabetology, Giovanni XXIII Children Hospital, Azienda Ospedaliero-Universitaria Consorziale, 70126 Bari, Italy; <email>giulia.paterno@policlinico.ba.it</email> (G.P.); <email>rosa.carella@policlinico.ba.it</email> (R.C.); <email>donatella.degiovanni@policlinico.ba.it</email> (D.D.G.)</aff><aff id="af2-pediatrrep-17-00056"><label>2</label>Medical Direction, Giovanni XXIII Children Hospital, Azienda Ospedaliero-Universitaria Consorziale, 70126 Bari, Italy; <email>livio.melpignano@policlinico.ba.it</email></aff><author-notes><corresp id="c1-pediatrrep-17-00056"><label>*</label>Correspondence: <email>albina.tummolo@policlinico.ba.it</email></corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>17</volume><issue>3</issue><elocation-id>56</elocation-id><history><date date-type="received"><day>12</day><month>3</month><year>2025</year></date><date date-type="rev-recd"><day>13</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>29</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Introduction: The psychosocial impact of living with an Inherited Metabolic Disorder (IMD) is becoming increasingly relevant and can have a significant impact on planning the future, conditioning the reproductive decisions made during adolescence and young adulthood. The aim of this paper is to explore thoughts about partner choices, parenthood and pregnancy among adolescents and young adults affected by IMDs. Methods: A cross-sectional study was performed. A sample of 23 patients affected by a range of IMDs were interviewed. Twenty-two questions were provided, distinguished into four main themes: partners, parenthood, pregnancy and need for information. Results: More than half of participants (57%) reported insecurities about relationships and declared that they were single for this reason, with most (70%) having a hope of having children in the future, although with the awareness and fear that they could also be affected. Almost all females (90%) consider themselves able to carry a pregnancy in a way similar to other women. There was the common need for more information about their potential fertility and parenthood linked to their condition. Conclusion: Being diagnosed with an IMD can influence personal decisions regarding relationships and reproduction. The early identification of issues in these domains may enhance referrals for personalized interventions and build more focused support programmes.</p></abstract><kwd-group><kwd>inherited metabolic disorders</kwd><kwd>partner choice</kwd><kwd>parenthood</kwd><kwd>fertility</kwd><kwd>pregnancy</kwd></kwd-group><funding-group><funding-statement>The authors declare no sources of study funding, including sponsorship, for the described work.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-pediatrrep-17-00056"><title>1. Introduction</title><p>Inherited metabolic disorders (IMDs) are a group of genetic conditions where the body&#x02019;s metabolism is disrupted due to defects in specific enzymes or proteins that are responsible for converting food into energy or for processing specific molecules in the body. These disorders are usually inherited in an autosomal recessive pattern, meaning that both copies of the gene in question must have mutations for the disorder to manifest.</p><p>IMDs can affect various metabolic pathways, including those responsible for breaking down proteins, fats and carbohydrates, as well as synthesizing essential molecules, such as hormones or neurotransmitters [<xref rid="B1-pediatrrep-17-00056" ref-type="bibr">1</xref>].</p><p>IMDs were first described by Sir Garrod in 1901 [<xref rid="B2-pediatrrep-17-00056" ref-type="bibr">2</xref>] and nowadays are increasingly recognised due to improved diagnostic technologies [<xref rid="B3-pediatrrep-17-00056" ref-type="bibr">3</xref>,<xref rid="B4-pediatrrep-17-00056" ref-type="bibr">4</xref>,<xref rid="B5-pediatrrep-17-00056" ref-type="bibr">5</xref>] and worldwide newborn screening programmes [<xref rid="B6-pediatrrep-17-00056" ref-type="bibr">6</xref>].</p><p>The literature provides robust evidence of improved treatment options for many IMDs [<xref rid="B7-pediatrrep-17-00056" ref-type="bibr">7</xref>,<xref rid="B8-pediatrrep-17-00056" ref-type="bibr">8</xref>], most of which were once deemed untreatable. As survival and quality of life improve, attention has shifted to new challenges in managing psychosocial aspects of living with IMDs [<xref rid="B9-pediatrrep-17-00056" ref-type="bibr">9</xref>,<xref rid="B10-pediatrrep-17-00056" ref-type="bibr">10</xref>,<xref rid="B11-pediatrrep-17-00056" ref-type="bibr">11</xref>].</p><p>Beyond the obvious health challenges related to a genetic disorder, patients with IMDs also experience psychosocial difficulties and challenges, as their day-by-day life may be strongly impacted not only by the disease&#x02019;s physical consequences, but also by the psychological stress of disease management and therapy [<xref rid="B12-pediatrrep-17-00056" ref-type="bibr">12</xref>,<xref rid="B13-pediatrrep-17-00056" ref-type="bibr">13</xref>,<xref rid="B14-pediatrrep-17-00056" ref-type="bibr">14</xref>]. This situation may have an effect on the social interactions and relationships of young individuals with their peers [<xref rid="B15-pediatrrep-17-00056" ref-type="bibr">15</xref>,<xref rid="B16-pediatrrep-17-00056" ref-type="bibr">16</xref>] and on the decision-making process regarding partner choices and reproductive decisions. Furthermore, many studies have provided evidence of possible genetic influences on several aspects of sexual behaviour, such as the desire to become parents and the propensities for marriage [<xref rid="B17-pediatrrep-17-00056" ref-type="bibr">17</xref>].</p><p>Thoughts about finding a partner and becoming parents become increasingly important, occupying a significant part of their future planning and expectations, from adolescence onwards [<xref rid="B18-pediatrrep-17-00056" ref-type="bibr">18</xref>,<xref rid="B19-pediatrrep-17-00056" ref-type="bibr">19</xref>]. In early adulthood, relationship building and family planning become increasingly relevant [<xref rid="B20-pediatrrep-17-00056" ref-type="bibr">20</xref>,<xref rid="B21-pediatrrep-17-00056" ref-type="bibr">21</xref>].</p><p>Although the psychological issues of young patients with genetic disorders are becoming increasingly recognized in clinical practice in recent years, evidence regarding partner perceptions, choices and reproductive decision making are still scarce and require more specific and detailed information. In a recent clinical survey on young adults affected by sickle cell disease, their reproductive experiences and intentions were analysed. Most (68%) were sexually active, and 45% reported contraception use; 92% did not desire a pregnancy in the near future [<xref rid="B22-pediatrrep-17-00056" ref-type="bibr">22</xref>].</p><p>In a qualitative study conducted by Severijns et al. on couples at risk of transmitting a genetic disease, feelings of guilt and fear were commonly reported and more in-depth decision support was required by patients [<xref rid="B23-pediatrrep-17-00056" ref-type="bibr">23</xref>].</p><p>Pregnancy-related complications and the risk of disease transmission may discourage reproductive decisions in young women with IMDs [<xref rid="B24-pediatrrep-17-00056" ref-type="bibr">24</xref>,<xref rid="B25-pediatrrep-17-00056" ref-type="bibr">25</xref>]. Phenylketonuria (PKU), one of the most common IMDs [<xref rid="B26-pediatrrep-17-00056" ref-type="bibr">26</xref>], represents a paradigm of this issue as it adds to the risk of transmissibility of the disease, along with the potential teratogenicity of Phenylalanine, during pregnancy, thus strongly influencing the woman&#x02019;s decisions [<xref rid="B27-pediatrrep-17-00056" ref-type="bibr">27</xref>,<xref rid="B28-pediatrrep-17-00056" ref-type="bibr">28</xref>].</p><p>Despite the improvements in medical care for women with genetic disorders leading to an increased number of women reaching reproductive age (Harris) [<xref rid="B25-pediatrrep-17-00056" ref-type="bibr">25</xref>], female patients affected by IMDs have been reported to be at risk of acute metabolic decompensation during catabolic stress periods, including labour, delivery and the postpartum period [<xref rid="B29-pediatrrep-17-00056" ref-type="bibr">29</xref>].</p><p>We hypothesized that young adults affected by IMDs may face greater difficulties in forming relationships and planning a family due to disease management burdens and inheritance concerns.</p><p>This study aimed to explore perceptions about partners, parenthood and pregnancy, while also expanding on the need for information and the preferred way to receive information, among adolescents and young patients affected by different forms of IMDs.</p></sec><sec id="sec2-pediatrrep-17-00056"><title>2. Materials and Methods</title><sec id="sec2dot1-pediatrrep-17-00056"><title>2.1. Design, Setting and Sample</title><p>This was a cross-sectional study based on a telephone survey conducted from July 2024 to September 2024 at the Division of Inherited Metabolic Disorders, Clinical Genetics and Diabetology, of Children Hospital Giovanni XXIII in Bari, Italy. This study was part of the support programme for adolescents&#x02019; health and social wellbeing held by the hospital. As part of the hospital support programme, a genetic counselling was offered to those who required it, also including contraceptive counselling if necessary.</p><p>This study formed part of the hospital&#x02019;s support programme for adolescent health and social well-being. Genetic and contraceptive counselling were offered as needed.</p><p>Inclusion criteria were as follows: males and females followed up for IMD, aged between 16 and 35 years. Low cognitive level, mild forms of the diseases, not requiring any treatment, irregular follow-up and diagnosis not confirmed by genetic analysis represented exclusion criteria. Participants were recruited by an invitation during a regular outpatient visit. Informed consent was obtained prior to telephone interviews.</p></sec><sec id="sec2dot2-pediatrrep-17-00056"><title>2.2. Data Collection</title><p>Google Forms [<xref rid="B30-pediatrrep-17-00056" ref-type="bibr">30</xref>] was used to administer the survey, which included 22 questions across four themes: expectations about having a partner and/or a spouse; propensity to have children in the future; capability to face a pregnancy (for female participants only). The questions also addressed whether they would like to receive more information and counselling about this context. Some samples of questions and related themes are reported in <xref rid="pediatrrep-17-00056-t001" ref-type="table">Table 1</xref>.</p><p>Both open- and close-ended questions were used. Participants could elaborate using optional text boxes. Telephone interviews were conducted by a single investigator. The interviews were based on a broad scoping review of the literature [<xref rid="B31-pediatrrep-17-00056" ref-type="bibr">31</xref>] and revised through discussion among investigators, all with clinical experience in following and treating IMDs. The survey was delivered for 2 months; the last interview was performed on 14 September 2024.</p><p>Data were anonymized using alphanumeric codes. Descriptive statistical analysis was performed using Microsoft<sup>&#x000ae;</sup> Excel 2016 MSO, version 2016. Continuous variables were expressed as mean (&#x000b1;standard deviation, SD) or median and range, depending on their distribution; categorical variables were reported as frequencies and percentages.</p><p>This study was conducted according to the guidelines of the &#x0201c;Declaration of Helsinki&#x0201d; and received ethics approval from the Local Ethics Committee IRCCS Istituto Oncologico &#x0201c;Gabriella Serio&#x0201d;, Bari, (Protocol No.: 1643/CEL).</p></sec></sec><sec sec-type="results" id="sec3-pediatrrep-17-00056"><title>3. Results</title><p>Thirty-two patients were initially contacted. Five did not respond after initial contact, and one declined participation. Twenty-three eligible patients completed the interviews, resulting in a 71% response rate.</p><p>Individual open and close-ended questions were asked, each lasting on average 15 min (between 10 and 20 min). The age range of the study participants was 18&#x02013;32; the majority were males (56%) and affected by PKU (56%). <xref rid="pediatrrep-17-00056-t002" ref-type="table">Table 2</xref> reports their main demographic characteristics and type of disease. Genetic confirmation was available, and the results from the genetic analysis are reported as <xref rid="app1-pediatrrep-17-00056" ref-type="app">Supplementary Material (Table S1)</xref>.</p><p>All participants had an IQ above 70 (minimum IQ was 71) and no motor or intellectual disabilities were reported. Additionally, 19 out of 23 (82%) individuals completed high school, 5 (21%) were attending university at the time of the survey, 3 were employed and 4 were neither studying nor working. Twenty-one (91%) individuals lived with their families; the remaining three males had either moved in with their partners or relocated for university.</p><p>
<bold>Theme 1: Partners</bold>
</p><p>Most of the participants (20/23, 87%) expressed an interest in a couple&#x02019;s relationship, but less than half of them (10/23, 43%) declared that they have a partner, of whom 5 were female (50% of all females) and 5 were male (38% of all males). Four participants (one female and three males) had never had a partner; their mean age was 20.7 &#x000b1; 2 years. None of the participants were married at the time of the survey. The mean age of those in a relationship was 25.3 years, compared to 23.4 years for single participants. Thirteen participants (57%) declared that they were insecure about sentimental relationships and declared that they were single for this reason. Concerns about the fact that the disease could frighten the partner, and that their disease-linked lifestyle was not compatible with the life of a couple, represented the main reported limitations.</p><p>Most participants (13/23, 57%) said they would disclose their condition early in a new relationship, often at the first meeting, to build trust and ensure compatibility:
<disp-quote><p><italic toggle="yes">&#x0201c;I would talk about my disease as soon as I have the opportunity to do it. I want to be sure that my boyfriend would be able to face the difficulties and challenges with me&#x0201d;.</italic></p><attrib><italic toggle="yes">(female, 27 years, urea cycle disorder)</italic></attrib></disp-quote></p><p>
<bold>Theme 2: Parenthood</bold>
</p><p>Most of the participants (16/23, 70%) hoped to have children in the future, and the remaining participants did not consider parenthood as a part of their future plans; the majority of this group were males (5), with a mean age of 24 &#x000b1; 4 years. Concerns about reduced fertility were exclusively expressed by females (four), who felt that their condition might limit the possibility of conceiving:
<disp-quote><p><italic toggle="yes">&#x0201c;I feel uncertain about the possibility of conceiving due to my disease, but I do not think I should be an inadequate parent&#x0201d;.</italic></p><attrib><italic toggle="yes">(female, 19 years PKU)</italic></attrib></disp-quote></p><p>Nearly half of all participants (12/23, 52%) expressed fear that their child might inherit the same disease, as they believe that it is likely that their genetic condition could be transmitted to sons. Therefore, they are aware that they face personal and ethical choices in the future:
<disp-quote><p><italic toggle="yes">&#x0201c;If I decide to have a child, I would ask my partner to do the genetic test to discover if he is carrier of the disease&#x0201d;.</italic></p><attrib><italic toggle="yes">(female, 21 years, galactosemia)</italic></attrib></disp-quote></p><p>
<bold>Theme 3: Pregnancy</bold>
</p><p>Almost all of the females who participated (9/10, 90%), had optimistic expectations about being able to carry a pregnancy similarly to other women., Nonetheless, half of them (five) believed that special assistance would be required during their pregnancy due to potential increased risks, such as nausea, vomiting or more frequent monitoring:
<disp-quote><p><italic toggle="yes">&#x0201c;I&#x02019;m not sure I can cope with the restricted diet and phenylalanine monitoring during pregnancy. I think I would need help in this period&#x0201d;.</italic></p><attrib><italic toggle="yes">(24 years, PKU)</italic></attrib></disp-quote></p><p>
<bold>Theme 4: Information</bold>
</p><p>The vast majority (20/23, 87%) of participants expressed a desire to receive more information about fertility and parenthood related to their condition. To the same extent, they would like to share experience in this context with people affected by the same condition. Three (13%) were not interested in further information, as they did not foresee parenthood in their future plans. They were all males, aged 23, 30 and 32 years, and two of them had declared that they have a partner.
<disp-quote><p><italic toggle="yes">&#x0201c;I live the relationship with my partner on a day-by-day basis and I&#x02019;m afraid that facing this topic may alter the equilibrium between me and my girlfriend&#x0201d;.</italic></p><attrib><italic toggle="yes">(male, 22 years, maple syrup urine disease)</italic></attrib></disp-quote></p><p>The preferred sources for receiving information were websites (11), followed by dedicated meetings with the metabolic team (6) and finally meeting with other experts in the field (3) (gynaecologists, obstetrics and neonatologists). Of those preferring websites, eight (72%) participants were under 25 years of age, and eight were males.</p><p>Only one participant reported a negative view of online information:
<disp-quote><p><italic toggle="yes">&#x0201c;I feel more confident in reading this information from a paper leaflet, because in this way I&#x02019;m sure about the source and the authors&#x0201d;.</italic></p><attrib><italic toggle="yes">(male, 18 years, PKU)</italic></attrib></disp-quote></p></sec><sec sec-type="discussion" id="sec4-pediatrrep-17-00056"><title>4. Discussion</title><p>This explorative cross-sectional study investigated, for the first time, thinking about partner choices, fertility and pregnancy among young subjects affected by IMDs. The results have pointed out some main findings: more than half of the participants felt insecure about sentimental relationships and declared that they were single for this reason, and most of the participants have a hope of having children in the future, although with the awareness and fear that they could be also affected. Fifty percent of the females had no partner at the time of this study; however, most of them consider themselves able to carry a pregnancy in a way similar to other women. There was a common need for more information about their potential fertility and parenthood linked to their condition, and the youngest patients preferred to receive this information by websites. A graphical representation of the key results of this study is reported in <xref rid="pediatrrep-17-00056-f001" ref-type="fig">Figure 1</xref>.</p><p><bold>Alternative Text:</bold> The figure provides a graphical representation of the key results of the study, with three pie charts and one bar chart. They represent, in different colors, the proportion of positive and negative responses about: having a partner, willing parenthood, being able to carry pregnancy, needing more information.</p><p>The perception and the choice of a potential partner for young individuals affected by IMDs can be complex and influenced by various factors, and it appears to represent a major limitation for our patients.</p><p>They may be hesitant to start a relationship with someone, as they may be concerned about the impact the disease management may have on the partner&#x02019;s quality of life. In particular, many IMDs require patients to follow a restricted diet regimen [<xref rid="B32-pediatrrep-17-00056" ref-type="bibr">32</xref>,<xref rid="B33-pediatrrep-17-00056" ref-type="bibr">33</xref>] and patients may worry about how their potential partner and their social circle in general would perceive this limitation. The social impact of a strict diet regimen represents an issue for young subjects and is the main reason for diet discontinuation in PKU patients since adolescence [<xref rid="B34-pediatrrep-17-00056" ref-type="bibr">34</xref>,<xref rid="B35-pediatrrep-17-00056" ref-type="bibr">35</xref>]. The diet burden may play a role in the partnership of these young subjects. In this context, it has been reported that personal experiences with an IMD, including its physical and emotional impacts, may guide an individual toward the choice of a partner who has a deep understanding and empathy for their situation [<xref rid="B36-pediatrrep-17-00056" ref-type="bibr">36</xref>], as also referred to by some of our patients.</p><p>In our study, about one-third of the participants felt anxious about having children, while others were more determined to overcome related challenges. The first group was mostly represented by males, whereas girls were more optimistic about the possibility of building a family with children, although this difference has not been confirmed by other studies on the general population.</p><p>The theme of potential infertility linked to a genetic condition is a classic critical point [<xref rid="B37-pediatrrep-17-00056" ref-type="bibr">37</xref>,<xref rid="B38-pediatrrep-17-00056" ref-type="bibr">38</xref>] which, despite ongoing medical improvement in reproductive technologies [<xref rid="B39-pediatrrep-17-00056" ref-type="bibr">39</xref>], remains a major cause of uncertainty.</p><p>Pregnancy may represent a crucial aspect for women affected by IMDs: it can be a complex period requiring careful and specialized management. It is essential that pregnant women with an inherited metabolic disease are carefully monitored during pregnancy, because of a higher risk of complications or the necessity of a different management of the underlying disorder, such as a change in pharmacotherapy and/or diet regimen, and an intensification in the monitoring rate [<xref rid="B40-pediatrrep-17-00056" ref-type="bibr">40</xref>,<xref rid="B41-pediatrrep-17-00056" ref-type="bibr">41</xref>,<xref rid="B42-pediatrrep-17-00056" ref-type="bibr">42</xref>]. In this context, a particular role is played by PKU, as suboptimal metabolic control, particularly in the first trimester, may be the cause of a plurimalformative syndrome of the foetus: the so-called Maternal PKU Syndrome [<xref rid="B43-pediatrrep-17-00056" ref-type="bibr">43</xref>,<xref rid="B44-pediatrrep-17-00056" ref-type="bibr">44</xref>]. It is advisable to plan a pregnancy in a timely manner and under the supervision of specialists. This may include counselling and meetings with the specialized team before conception, to be sure that satisfactory Phe level control is reached. The optimistic consideration of a future pregnancy from our patients, albeit with the awareness of needing adjunctive support in this period, is confirmative of the common experience of the willingness and determination of PKU women to follow a very restrictive diet to ensure a positive newborn outcome [<xref rid="B27-pediatrrep-17-00056" ref-type="bibr">27</xref>,<xref rid="B28-pediatrrep-17-00056" ref-type="bibr">28</xref>].</p><p>In the background, there is the common desire of participants for further knowledge and the awareness that many aspects of this theme deserve more information. Unsurprisingly, websites were the preferred source among the younger population. In current clinical practice, healthcare teams are increasingly faced with interpreting and responding to information patients obtain from online sources. It is essential to ensure that such information is accurate and critically evaluated with the help of experts.</p><p>This study has some limitations: the sample size is small and did not allow for distinction among different types of IMDs; however, this is expected considering that IMDs are rare diseases. Furthermore, the population was heterogeneous in terms of their background and type of treatment, which are both features that can influence partner choices and family perspectives.</p></sec><sec sec-type="conclusions" id="sec5-pediatrrep-17-00056"><title>5. Conclusions</title><p>Uncertainty surrounding relationships, potential infertility and pregnancy management was common among the participants. While uncertainty may not be easily resolved, a system that includes families and healthcare teams can aid in navigating these complex decisions, which, in some cases, may start in early adolescence. Emotional support and practical assistance, with contraceptive advice, should be offered to young people with IMDs, helping them to face the complexities of relationships and family planning.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-pediatrrep-17-00056"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/pediatric17030056/s1">https://www.mdpi.com/article/10.3390/pediatric17030056/s1</uri>. Table S1. Patients&#x02019; Genetic profile. </p><supplementary-material id="pediatrrep-17-00056-s001" position="float" content-type="local-data"><media xlink:href="pediatrrep-17-00056-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualisation, original draft preparation, writing and review of the manuscript, A.T.; resources and data curation, G.P., R.C. and D.D.G.; review and editing, L.M. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study was conducted in accordance with the Declaration of Helsinki and was approved by an Institutional Review Board/Ethics committee. See details in the Methods Section. This study received an exemption from an Institutional Review Board/Ethics committee IRCCS Istituto Oncologico &#x0201c; Gabriella Serio&#x0201d; (Prot. 497 of 16/07/2024- 1643/CEL); see details in the Methods Section.</p></notes><notes><title>Informed Consent Statement</title><p>Written informed consent was obtained from the participants of this study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data that support the findings of this study are available on request from the corresponding author (A.T.). The data are not publicly available because they contain information that could compromise the privacy of the research participants.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pediatrrep-17-00056"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>C.R.</given-names></name>
<name><surname>Rahman</surname><given-names>S.</given-names></name>
<name><surname>Keller</surname><given-names>M.</given-names></name>
<name><surname>Zschocke</surname><given-names>J.</given-names></name>
<name><surname>Group</surname><given-names>I.A.</given-names></name>
</person-group><article-title>An international classification of inherited metabolic disorders (ICIMD)</article-title><source>J. Inherit. Metab. Dis.</source><year>2021</year><volume>44</volume><fpage>164</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1002/jimd.12348</pub-id><pub-id pub-id-type="pmid">33340416</pub-id>
</element-citation></ref><ref id="B2-pediatrrep-17-00056"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garrod</surname><given-names>A.E.</given-names></name>
</person-group><article-title>About Alkaptonuria</article-title><source>Lancet</source><year>1901</year><volume>2</volume><fpage>1484</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(01)74537-0</pub-id></element-citation></ref><ref id="B3-pediatrrep-17-00056"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Karnebeek</surname><given-names>C.D.M.</given-names></name>
<name><surname>Wortmann</surname><given-names>S.B.</given-names></name>
<name><surname>Tarailo-Graovac</surname><given-names>M.</given-names></name>
<name><surname>Langeveld</surname><given-names>M.</given-names></name>
<name><surname>Ferreira</surname><given-names>C.R.</given-names></name>
<name><surname>van de Kamp</surname><given-names>J.M.</given-names></name>
<name><surname>Hollak</surname><given-names>C.E.</given-names></name>
<name><surname>Wasserman</surname><given-names>W.W.</given-names></name>
<name><surname>Waterham</surname><given-names>H.R.</given-names></name>
<name><surname>Wevers</surname><given-names>R.A.</given-names></name>
<etal/>
</person-group><article-title>The role of the clinician in the multi-omics era: Are you ready?</article-title><source>J. Inherit. Metab. Dis.</source><year>2018</year><volume>41</volume><fpage>571</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1007/s10545-017-0128-1</pub-id><pub-id pub-id-type="pmid">29362952</pub-id>
</element-citation></ref><ref id="B4-pediatrrep-17-00056"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>E.A.</given-names></name>
<name><surname>Buijs</surname><given-names>M.J.N.</given-names></name>
<name><surname>Wijngaard</surname><given-names>R.</given-names></name>
<name><surname>Daams</surname><given-names>J.G.</given-names></name>
<name><surname>Datema</surname><given-names>M.R.</given-names></name>
<name><surname>Engelen</surname><given-names>M.</given-names></name>
<name><surname>van Karnebeek</surname><given-names>C.D.M.</given-names></name>
<name><surname>Oud</surname><given-names>M.M.</given-names></name>
<name><surname>Vaz</surname><given-names>F.M.</given-names></name>
<name><surname>Wamelink</surname><given-names>M.M.C.</given-names></name>
<etal/>
</person-group><article-title>Inherited metabolic disorders in adults: Systematic review on patient characteristics and diagnostic yield of broad sequencing techniques (exome and genome sequencing)</article-title><source>Front. Neurol.</source><year>2023</year><volume>14</volume><elocation-id>1206106</elocation-id><pub-id pub-id-type="doi">10.3389/fneur.2023.1206106</pub-id><pub-id pub-id-type="pmid">37560457</pub-id>
</element-citation></ref><ref id="B5-pediatrrep-17-00056"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Slenter</surname><given-names>D.N.</given-names></name>
<name><surname>Hemel</surname><given-names>I.M.G.M.</given-names></name>
<name><surname>Evelo</surname><given-names>C.T.</given-names></name>
<name><surname>Bierau</surname><given-names>J.</given-names></name>
<name><surname>Willighagen</surname><given-names>E.L.</given-names></name>
<name><surname>Steinbusch</surname><given-names>L.K.M.</given-names></name>
</person-group><article-title>Extending inherited metabolic disorder diagnostics with biomarker interaction visualizations</article-title><source>Orphanet J. Rare Dis.</source><year>2023</year><volume>18</volume><fpage>95</fpage><pub-id pub-id-type="doi">10.1186/s13023-023-02683-9</pub-id><pub-id pub-id-type="pmid">37101200</pub-id>
</element-citation></ref><ref id="B6-pediatrrep-17-00056"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Loeber</surname><given-names>J.G.</given-names></name>
<name><surname>Platis</surname><given-names>D.</given-names></name>
<name><surname>Zetterstr&#x000f6;m</surname><given-names>R.H.</given-names></name>
<name><surname>Almashanu</surname><given-names>S.</given-names></name>
<name><surname>Boemer</surname><given-names>F.</given-names></name>
<name><surname>Bonham</surname><given-names>J.R.</given-names></name>
<name><surname>Borde</surname><given-names>P.</given-names></name>
<name><surname>Brincat</surname><given-names>I.</given-names></name>
<name><surname>Cheillan</surname><given-names>D.</given-names></name>
<name><surname>Dekkers</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since</article-title><source>Int. J. Neonatal Screen.</source><year>2010</year><volume>7</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.3390/ijns7010015</pub-id><pub-id pub-id-type="pmid">33808002</pub-id>
</element-citation></ref><ref id="B7-pediatrrep-17-00056"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yilmaz</surname><given-names>B.S.</given-names></name>
<name><surname>Gurung</surname><given-names>S.</given-names></name>
<name><surname>Perocheau</surname><given-names>D.</given-names></name>
<name><surname>Counsell</surname><given-names>J.</given-names></name>
<name><surname>Baruteau</surname><given-names>J.</given-names></name>
</person-group><article-title>Gene therapy for inherited metabolic diseases</article-title><source>J. Mother Child</source><year>2020</year><volume>24</volume><fpage>53</fpage><lpage>64</lpage></element-citation></ref><ref id="B8-pediatrrep-17-00056"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoytema van Konijnenburg</surname><given-names>E.M.M.</given-names></name>
<name><surname>Wortmann</surname><given-names>S.B.</given-names></name>
<name><surname>Koelewijn</surname><given-names>M.</given-names></name>
<name><surname>Tseng</surname><given-names>L.A.</given-names></name>
<name><surname>Houben</surname><given-names>R.</given-names></name>
<name><surname>St&#x000f6;ckler-Ipsiroglu</surname><given-names>S.</given-names></name>
<name><surname>Ferreira</surname><given-names>C.R.</given-names></name>
<name><surname>van Karnebeek</surname><given-names>C.D.M.</given-names></name>
</person-group><article-title>Treatable inherited metabolic disorders causing intellectual disability: Review and digital app</article-title><source>Orphanet J. Rare Dis.</source><year>2021</year><volume>16</volume><fpage>170</fpage><pub-id pub-id-type="doi">10.1186/s13023-021-01727-2</pub-id><pub-id pub-id-type="pmid">33845862</pub-id>
</element-citation></ref><ref id="B9-pediatrrep-17-00056"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pascoal</surname><given-names>C.</given-names></name>
<name><surname>Brasil</surname><given-names>S.</given-names></name>
<name><surname>Francisco</surname><given-names>R.</given-names></name>
<name><surname>Marques-da-Silva</surname><given-names>D.</given-names></name>
<name><surname>Rafalko</surname><given-names>A.</given-names></name>
<name><surname>Jaeken</surname><given-names>J.</given-names></name>
<name><surname>Videira</surname><given-names>P.A.</given-names></name>
<name><surname>Barros</surname><given-names>L.</given-names></name>
<name><surname>Dos Reis Ferreira</surname><given-names>V.</given-names></name>
</person-group><article-title>Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: A scoping review</article-title><source>Orphanet J. Rare Dis.</source><year>2018</year><volume>13</volume><fpage>215</fpage><pub-id pub-id-type="doi">10.1186/s13023-018-0953-9</pub-id><pub-id pub-id-type="pmid">30486833</pub-id>
</element-citation></ref><ref id="B10-pediatrrep-17-00056"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cazzorla</surname><given-names>C.</given-names></name>
<name><surname>Del Rizzo</surname><given-names>M.</given-names></name>
<name><surname>Burgard</surname><given-names>P.</given-names></name>
<name><surname>Zanco</surname><given-names>C.</given-names></name>
<name><surname>Bordugo</surname><given-names>A.</given-names></name>
<name><surname>Burlina</surname><given-names>A.B.</given-names></name>
<name><surname>Burlina</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseases</article-title><source>Mol. Genet. Metab.</source><year>2012</year><volume>106</volume><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2012.02.008</pub-id><pub-id pub-id-type="pmid">22398241</pub-id>
</element-citation></ref><ref id="B11-pediatrrep-17-00056"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tummolo</surname><given-names>A.</given-names></name>
<name><surname>Carella</surname><given-names>R.</given-names></name>
<name><surname>Paterno</surname><given-names>G.</given-names></name>
<name><surname>Bartolomeo</surname><given-names>N.</given-names></name>
<name><surname>Giotta</surname><given-names>M.</given-names></name>
<name><surname>Dicintio</surname><given-names>A.</given-names></name>
<name><surname>De Giovanni</surname><given-names>D.</given-names></name>
<name><surname>Fischetto</surname><given-names>R.</given-names></name>
</person-group><article-title>Body Composition in Adolescent PKU Patients: Beyond Fat Mass</article-title><source>Children</source><year>2022</year><volume>9</volume><elocation-id>1353</elocation-id><pub-id pub-id-type="doi">10.3390/children9091353</pub-id><pub-id pub-id-type="pmid">36138662</pub-id>
</element-citation></ref><ref id="B12-pediatrrep-17-00056"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weber</surname><given-names>S.L.</given-names></name>
<name><surname>Segal</surname><given-names>S.</given-names></name>
<name><surname>Packman</surname><given-names>W.</given-names></name>
</person-group><article-title>Inborn errors of metabolism: Psychosocial challenges and proposed family systems model of intervention</article-title><source>Mol. Genet. Metab.</source><year>2012</year><volume>105</volume><fpage>537</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2012.01.014</pub-id><pub-id pub-id-type="pmid">22532988</pub-id>
</element-citation></ref><ref id="B13-pediatrrep-17-00056"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khangura</surname><given-names>S.D.</given-names></name>
<name><surname>Tingley</surname><given-names>K.</given-names></name>
<name><surname>Chakraborty</surname><given-names>P.</given-names></name>
<name><surname>Coyle</surname><given-names>D.</given-names></name>
<name><surname>Kronick</surname><given-names>J.B.</given-names></name>
<name><surname>Laberge</surname><given-names>A.M.</given-names></name>
<name><surname>Little</surname><given-names>J.</given-names></name>
<name><surname>Miller</surname><given-names>F.A.</given-names></name>
<name><surname>Mitchell</surname><given-names>J.J.</given-names></name>
<name><surname>Prasad</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Child and family experiences with inborn errors of metabolism: A qualitative interview study with representatives of patient groups</article-title><source>J. Inherit. Metab. Dis.</source><year>2016</year><volume>39</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1007/s10545-015-9881-1</pub-id><pub-id pub-id-type="pmid">26209272</pub-id>
</element-citation></ref><ref id="B14-pediatrrep-17-00056"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Siddiq</surname><given-names>S.</given-names></name>
<name><surname>Wilson</surname><given-names>B.J.</given-names></name>
<name><surname>Graham</surname><given-names>I.D.</given-names></name>
<name><surname>Lamoureux</surname><given-names>M.</given-names></name>
<name><surname>Khangura</surname><given-names>S.D.</given-names></name>
<name><surname>Tingley</surname><given-names>K.</given-names></name>
<name><surname>Tessier</surname><given-names>L.</given-names></name>
<name><surname>Chakraborty</surname><given-names>P.</given-names></name>
<name><surname>Coyle</surname><given-names>D.</given-names></name>
<name><surname>Dyack</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Experiences of caregivers of children with inherited metabolic diseases: A qualitative study</article-title><source>Orphanet J. Rare Dis.</source><year>2016</year><volume>11</volume><fpage>168</fpage><pub-id pub-id-type="doi">10.1186/s13023-016-0548-2</pub-id><pub-id pub-id-type="pmid">27927250</pub-id>
</element-citation></ref><ref id="B15-pediatrrep-17-00056"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sestini</surname><given-names>S.</given-names></name>
<name><surname>Paneghetti</surname><given-names>L.</given-names></name>
<name><surname>Lampe</surname><given-names>C.</given-names></name>
<name><surname>Betti</surname><given-names>G.</given-names></name>
<name><surname>Bond</surname><given-names>S.</given-names></name>
<name><surname>Bellettato</surname><given-names>C.M.</given-names></name>
<name><surname>Maurizio</surname><given-names>S.</given-names></name>
</person-group><article-title>Social and medical needs of rare metabolic patients: Results from a MetabERN survey</article-title><source>Orphanet J. Rare Dis.</source><year>2021</year><volume>16</volume><fpage>336</fpage><pub-id pub-id-type="doi">10.1186/s13023-021-01948-5</pub-id><pub-id pub-id-type="pmid">34344397</pub-id>
</element-citation></ref><ref id="B16-pediatrrep-17-00056"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Castro</surname><given-names>R.</given-names></name>
<name><surname>Senecat</surname><given-names>J.</given-names></name>
<name><surname>de Chalendar</surname><given-names>M.</given-names></name>
<name><surname>Vajda</surname><given-names>I.</given-names></name>
<name><surname>Dan</surname><given-names>D.</given-names></name>
<name><surname>Boncz</surname><given-names>B.</given-names></name>
</person-group><article-title>Bridging the gap between health and social care for rare diseases: Key issues and innovative solutions</article-title><source>Rare Diseases Epidemiology: Update and Overview</source><person-group person-group-type="editor">
<name><surname>Posada de la Paz</surname><given-names>M.</given-names></name>
<name><surname>Taruscio</surname><given-names>D.</given-names></name>
<name><surname>Groft</surname><given-names>S.C.</given-names></name>
</person-group><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2017</year><fpage>605</fpage><lpage>627</lpage></element-citation></ref><ref id="B17-pediatrrep-17-00056"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jannini</surname><given-names>E.A.</given-names></name>
<name><surname>Burri</surname><given-names>A.</given-names></name>
<name><surname>Jern</surname><given-names>P.</given-names></name>
<name><surname>Novelli</surname><given-names>G.</given-names></name>
</person-group><article-title>Genetics of Human Sexual Behavior: Where we are, Where we are going</article-title><source>Sex. Med. Rev.</source><year>2015</year><volume>3</volume><fpage>65</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1002/smrj.46</pub-id><pub-id pub-id-type="pmid">27784547</pub-id>
</element-citation></ref><ref id="B18-pediatrrep-17-00056"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hegde</surname><given-names>A.</given-names></name>
<name><surname>Chandran</surname><given-names>S.</given-names></name>
<name><surname>Pattnaik</surname><given-names>J.I.</given-names></name>
</person-group><article-title>Understanding Adolescent Sexuality: A Developmental Perspective</article-title><source>J. Psychosexual Health</source><year>2022</year><volume>4</volume><fpage>237</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1177/26318318221107598</pub-id></element-citation></ref><ref id="B19-pediatrrep-17-00056"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sujita</surname><given-names>K.K.</given-names></name>
<name><surname>Ananya</surname><given-names>C.</given-names></name>
<name><surname>Abhishek</surname><given-names>P.S.</given-names></name>
</person-group><article-title>Understanding normal development of adolescent sexuality: A bumpy ride</article-title><source>J. Hum. Reprod. Sci.</source><year>2015</year><volume>8</volume><fpage>70</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">26157296</pub-id>
</element-citation></ref><ref id="B20-pediatrrep-17-00056"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arnett</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Conceptions of the transition to adulthood among emerging adults in American ethnic groups</article-title><source>New Dir. Child Adolesc. Dev.</source><year>2003</year><volume>2003</volume><fpage>63</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1002/cd.75</pub-id></element-citation></ref><ref id="B21-pediatrrep-17-00056"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meier</surname><given-names>A.</given-names></name>
<name><surname>Allen</surname><given-names>G.</given-names></name>
</person-group><article-title>Intimate relationship development during the transition to adulthood: Differences by social class</article-title><source>New Dir. Child Adolesc. Dev.</source><year>2008</year><volume>2008</volume><fpage>25</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1002/cd.207</pub-id></element-citation></ref><ref id="B22-pediatrrep-17-00056"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>E.</given-names></name>
<name><surname>Linton</surname><given-names>E.</given-names></name>
<name><surname>Steawart</surname><given-names>R.</given-names></name>
<name><surname>Lanzkron</surname><given-names>S.M.</given-names></name>
<name><surname>Pecker</surname><given-names>L.H.</given-names></name>
</person-group><article-title>Young Adults with Sickle Cell Disease (SCD) HAVE LOW INTEREST IN Genetic counseling and sinckle cell trait testing for sexual parteners</article-title><source>Blood</source><year>2020</year><volume>13</volume><issue>(Suppl. 1)</issue><fpage>1</fpage><lpage>2</lpage></element-citation></ref><ref id="B23-pediatrrep-17-00056"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Severijns</surname><given-names>Y.</given-names></name>
<name><surname>de Die-Smulders</surname><given-names>C.E.M.</given-names></name>
<name><surname>G&#x000fc;ltzow</surname><given-names>T.</given-names></name>
<name><surname>de Vries</surname><given-names>H.</given-names></name>
<name><surname>van Osch</surname><given-names>L.A.D.M.</given-names></name>
</person-group><article-title>Hereditary diseases and child wish: Exploring motives, considerations, and the (joint) decision-making process of genetically at-risk couples</article-title><source>J. Community Genet.</source><year>2021</year><volume>12</volume><fpage>325</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1007/s12687-021-00510-x</pub-id><pub-id pub-id-type="pmid">33611773</pub-id>
</element-citation></ref><ref id="B24-pediatrrep-17-00056"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chetty</surname><given-names>S.</given-names></name>
<name><surname>Norton</surname><given-names>M.E.</given-names></name>
</person-group><article-title>Obstetric care in women with genetic disorders</article-title><source>Best Pract. Res. Clin. Obstet. Gynaecol.</source><year>2017</year><volume>42</volume><fpage>86</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.bpobgyn.2017.03.006</pub-id><pub-id pub-id-type="pmid">28392223</pub-id>
</element-citation></ref><ref id="B25-pediatrrep-17-00056"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harris</surname><given-names>S.</given-names></name>
<name><surname>Vora</surname><given-names>N.L.</given-names></name>
</person-group><article-title>Maternal Genetic Disorders in Pregnancy</article-title><source>Obstet. Gynecol. Clin. N. Am.</source><year>2018</year><volume>45</volume><fpage>249</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.ogc.2018.01.010</pub-id></element-citation></ref><ref id="B26-pediatrrep-17-00056"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Spronsen</surname><given-names>F.J.</given-names></name>
<name><surname>Blau</surname><given-names>N.</given-names></name>
<name><surname>Harding</surname><given-names>C.</given-names></name>
<name><surname>Burlina</surname><given-names>A.</given-names></name>
<name><surname>Longo</surname><given-names>N.</given-names></name>
<name><surname>Bosch</surname><given-names>A.M.</given-names></name>
</person-group><article-title>Phenylketonuria</article-title><source>Nat. Rev. Dis. Primers</source><year>2021</year><volume>7</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.1038/s41572-021-00267-0</pub-id><pub-id pub-id-type="pmid">34017006</pub-id>
</element-citation></ref><ref id="B27-pediatrrep-17-00056"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grohmann-Held</surname><given-names>K.</given-names></name>
<name><surname>Burgard</surname><given-names>P.</given-names></name>
<name><surname>Baerwald</surname><given-names>C.G.O.</given-names></name>
<name><surname>Beblo</surname><given-names>S.</given-names></name>
<name><surname>Vom Dahl</surname><given-names>S.</given-names></name>
<name><surname>Das</surname><given-names>A.</given-names></name>
<name><surname>Dokoupil</surname><given-names>K.</given-names></name>
<name><surname>Fleissner</surname><given-names>S.</given-names></name>
<name><surname>Freisinger</surname><given-names>P.</given-names></name>
<name><surname>Heddrich-Ellerbrok</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Impact of pregnancy planning and preconceptual dietary training on metabolic control and offspring&#x02019;s outcome in phenylketonuria</article-title><source>J. Inherit. Metab. Dis.</source><year>2022</year><volume>45</volume><fpage>1070</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1002/jimd.12544</pub-id><pub-id pub-id-type="pmid">36054426</pub-id>
</element-citation></ref><ref id="B28-pediatrrep-17-00056"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Y&#x00131;ld&#x00131;z</surname><given-names>Y.</given-names></name>
<name><surname>Sivri</surname><given-names>H.S.</given-names></name>
</person-group><article-title>Maternal phenylketonuria in Turkey: Outcomes of 71 pregnancies and issues in management</article-title><source>Eur. J. Pediatr.</source><year>2019</year><volume>178</volume><fpage>1005</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1007/s00431-019-03387-8</pub-id><pub-id pub-id-type="pmid">31053953</pub-id>
</element-citation></ref><ref id="B29-pediatrrep-17-00056"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mendez-Figueroa</surname><given-names>H.</given-names></name>
<name><surname>Lamance</surname><given-names>K.</given-names></name>
<name><surname>Sutton</surname><given-names>V.R.</given-names></name>
<name><surname>Aagaard-Tillery</surname><given-names>K.</given-names></name>
<name><surname>Van den Veyver</surname><given-names>I.</given-names></name>
</person-group><article-title>Management of ornithine transcarbamylase deficiency in pregnancy</article-title><source>Am. J. Perinatol.</source><year>2010</year><volume>27</volume><fpage>775</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1055/s-0030-1254240</pub-id><pub-id pub-id-type="pmid">20458665</pub-id>
</element-citation></ref><ref id="B30-pediatrrep-17-00056"><label>30.</label><element-citation publication-type="webpage"><article-title>Google Forms: Strumento di Creazione di Moduli Online|Google Workspace</article-title><comment>Available online: <ext-link xlink:href="https://docs.google.com/forms/u/0/?pli=1" ext-link-type="uri">https://docs.google.com/forms/u/0/?pli=1</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-05-05">(accessed on 5 May 2023)</date-in-citation></element-citation></ref><ref id="B31-pediatrrep-17-00056"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thorne</surname><given-names>S.</given-names></name>
<name><surname>Reimer Kirkham</surname><given-names>S.</given-names></name>
<name><surname>O&#x02019;Flynn-Magee</surname><given-names>K.</given-names></name>
</person-group><article-title>The analytic challenge in interpretive description</article-title><source>Int. J. Qual. Methods</source><year>2004</year><volume>3</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1177/160940690400300101</pub-id></element-citation></ref><ref id="B32-pediatrrep-17-00056"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Singh</surname><given-names>R.H.</given-names></name>
</person-group><article-title>Nutritional management of patients with urea cycle disorders</article-title><source>J. Inherit. Metab. Dis.</source><year>2007</year><volume>30</volume><fpage>880</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1007/s10545-007-0718-4</pub-id><pub-id pub-id-type="pmid">18034368</pub-id>
</element-citation></ref><ref id="B33-pediatrrep-17-00056"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boyer</surname><given-names>S.W.</given-names></name>
<name><surname>Barclay</surname><given-names>L.J.</given-names></name>
<name><surname>Burrage</surname><given-names>L.C.</given-names></name>
</person-group><article-title>Inherited Metabolic Disorders: Aspects of Chronic Nutrition Management</article-title><source>Nutr. Clin. Pract. Off. Publ. Am. Soc. Parenter. Enter. Nutr.</source><year>2015</year><volume>30</volume><fpage>502</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1177/0884533615586201</pub-id></element-citation></ref><ref id="B34-pediatrrep-17-00056"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>MCdonald</surname><given-names>A.</given-names></name>
<name><surname>van Rijn</surname><given-names>M.</given-names></name>
<name><surname>Feillet</surname><given-names>F.</given-names></name>
<name><surname>Lund</surname><given-names>A.M.</given-names></name>
<name><surname>Bernstein</surname><given-names>L.</given-names></name>
<name><surname>Bosch</surname><given-names>A.M.</given-names></name>
<name><surname>Gizewska</surname><given-names>M.</given-names></name>
<name><surname>van Spronsen</surname><given-names>F.J.</given-names></name>
</person-group><article-title>Adherence issues in inherited metabolic disorders treated by low natural protein diets</article-title><source>Ann. Nutr. Metab.</source><year>2012</year><volume>61</volume><fpage>289</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1159/000342256</pub-id><pub-id pub-id-type="pmid">23208158</pub-id>
</element-citation></ref><ref id="B35-pediatrrep-17-00056"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cazzorla</surname><given-names>C.</given-names></name>
<name><surname>Bensi</surname><given-names>G.</given-names></name>
<name><surname>Biasucci</surname><given-names>G.</given-names></name>
<name><surname>Leuzzi</surname><given-names>V.</given-names></name>
<name><surname>Manti</surname><given-names>F.</given-names></name>
<name><surname>Musumeci</surname><given-names>A.</given-names></name>
<name><surname>Papadia</surname><given-names>F.</given-names></name>
<name><surname>Stoppioni</surname><given-names>V.</given-names></name>
<name><surname>Tummolo</surname><given-names>A.</given-names></name>
<name><surname>Vendemiale</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Living with phenylketonuria in adulthood: The PKU ATTITUDE study</article-title><source>Mol. Genet. Metab. Rep.</source><year>2018</year><volume>16</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.ymgmr.2018.06.007</pub-id><pub-id pub-id-type="pmid">30069431</pub-id>
</element-citation></ref><ref id="B36-pediatrrep-17-00056"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eriksson</surname><given-names>E.</given-names></name>
<name><surname>Wej&#x000e5;ker</surname><given-names>M.</given-names></name>
<name><surname>Danhard</surname><given-names>A.</given-names></name>
<name><surname>Nilsson</surname><given-names>A.</given-names></name>
<name><surname>Kristofferzon</surname><given-names>M.L.</given-names></name>
</person-group><article-title>Living with a spouse with chronic illness&#x02014;The challenge of balancing demands and resources</article-title><source>BMC Public Health</source><year>2019</year><volume>19</volume><elocation-id>422</elocation-id><pub-id pub-id-type="doi">10.1186/s12889-019-6800-7</pub-id><pub-id pub-id-type="pmid">31014309</pub-id>
</element-citation></ref><ref id="B37-pediatrrep-17-00056"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zorrilla</surname><given-names>M.</given-names></name>
<name><surname>Yatsenko</surname><given-names>A.N.</given-names></name>
</person-group><article-title>The Genetics of Infertility: Current Status of the Field</article-title><source>Curr. Genet. Med. Rep.</source><year>2013</year><volume>1</volume><fpage>247</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1007/s40142-013-0027-1</pub-id></element-citation></ref><ref id="B38-pediatrrep-17-00056"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tar&#x000ed;n</surname><given-names>J.J.</given-names></name>
<name><surname>A Garc&#x000ed;a-P&#x000e9;rez</surname><given-names>M.</given-names></name>
<name><surname>Hamatani</surname><given-names>T.</given-names></name>
<name><surname>Cano</surname><given-names>A.</given-names></name>
</person-group><article-title>Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases</article-title><source>Reprod. Biol. Endocrinol.</source><year>2015</year><volume>13</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.1186/s12958-015-0029-9</pub-id><pub-id pub-id-type="pmid">25880215</pub-id>
</element-citation></ref><ref id="B39-pediatrrep-17-00056"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davies</surname><given-names>M.J.</given-names></name>
<name><surname>Moore</surname><given-names>V.M.</given-names></name>
<name><surname>Willson</surname><given-names>K.J.</given-names></name>
<name><surname>Van Essen</surname><given-names>P.</given-names></name>
<name><surname>Priest</surname><given-names>K.</given-names></name>
<name><surname>Scott</surname><given-names>H.</given-names></name>
<name><surname>Haan</surname><given-names>E.A.</given-names></name>
<name><surname>Chan</surname><given-names>A.</given-names></name>
</person-group><article-title>Reproductive technologies and the risk of birth defects</article-title><source>N. Engl. J. Med.</source><year>2012</year><volume>366</volume><fpage>1803</fpage><lpage>1813</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1008095</pub-id><pub-id pub-id-type="pmid">22559061</pub-id>
</element-citation></ref><ref id="B40-pediatrrep-17-00056"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stepien</surname><given-names>K.M.</given-names></name>
<name><surname>Geberhiwot</surname><given-names>T.</given-names></name>
<name><surname>Hendriksz</surname><given-names>C.J.</given-names></name>
<name><surname>Treacy</surname><given-names>E.P.</given-names></name>
</person-group><article-title>Challenges in diagnosing and managing adult patients with urea cycle disorders</article-title><source>J. Inherit. Metab. Dis.</source><year>2019</year><volume>42</volume><fpage>1136</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1002/jimd.12096</pub-id><pub-id pub-id-type="pmid">30932189</pub-id>
</element-citation></ref><ref id="B41-pediatrrep-17-00056"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shakerdi</surname><given-names>L.A.</given-names></name>
<name><surname>Gillman</surname><given-names>B.</given-names></name>
<name><surname>Corcoran</surname><given-names>E.</given-names></name>
<name><surname>McNulty</surname><given-names>J.</given-names></name>
<name><surname>Treacy</surname><given-names>E.P.</given-names></name>
</person-group><article-title>Organic Aciduria Disorders in Pregnancy: An Overview of Metabolic Considerations</article-title><source>Metabolites</source><year>2023</year><volume>13</volume><elocation-id>518</elocation-id><pub-id pub-id-type="doi">10.3390/metabo13040518</pub-id><pub-id pub-id-type="pmid">37110176</pub-id>
</element-citation></ref><ref id="B42-pediatrrep-17-00056"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bouchlariotou</surname><given-names>S.</given-names></name>
<name><surname>Tsikouras</surname><given-names>P.</given-names></name>
<name><surname>Maroulis</surname><given-names>G.</given-names></name>
</person-group><article-title>Undiagnosed maternal phenylketonuria: Own clinical experience and literature review</article-title><source>J. Matern.-Fetal Neonatal Med.</source><year>2009</year><volume>22</volume><fpage>943</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1080/14767050902994697</pub-id><pub-id pub-id-type="pmid">19557660</pub-id>
</element-citation></ref><ref id="B43-pediatrrep-17-00056"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burlina</surname><given-names>A.</given-names></name>
<name><surname>Biasucci</surname><given-names>G.</given-names></name>
<name><surname>Carbone</surname><given-names>M.T.</given-names></name>
<name><surname>Cazzorla</surname><given-names>C.</given-names></name>
<name><surname>Paci</surname><given-names>S.</given-names></name>
<name><surname>Pochiero</surname><given-names>F.</given-names></name>
<name><surname>Spada</surname><given-names>M.</given-names></name>
<name><surname>Tummolo</surname><given-names>A.</given-names></name>
<name><surname>Zuvadelli</surname><given-names>J.</given-names></name>
<name><surname>Leuzzi</surname><given-names>V.</given-names></name>
</person-group><article-title>Italian national consensus statement on management and pharmacological treatment of phenylketonuria</article-title><source>Orphanet J. Rare Dis.</source><year>2021</year><volume>16</volume><fpage>476</fpage><pub-id pub-id-type="doi">10.1186/s13023-021-02086-8</pub-id><pub-id pub-id-type="pmid">34784942</pub-id>
</element-citation></ref><ref id="B44-pediatrrep-17-00056"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rohde</surname><given-names>C.</given-names></name>
<name><surname>Thiele</surname><given-names>A.G.</given-names></name>
<name><surname>Baerwald</surname><given-names>C.</given-names></name>
<name><surname>Ascherl</surname><given-names>R.G.</given-names></name>
<name><surname>Lier</surname><given-names>D.</given-names></name>
<name><surname>Och</surname><given-names>U.</given-names></name>
<name><surname>Heller</surname><given-names>C.</given-names></name>
<name><surname>Jung</surname><given-names>A.</given-names></name>
<name><surname>Sch&#x000f6;nherr</surname><given-names>K.</given-names></name>
<name><surname>Joerg-Streller</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Preventing maternal phenylketonuria (PKU) syndrome: Important factors to achieve good metabolic control throughout pregnancy</article-title><source>Orphanet J. Rare Dis.</source><year>2021</year><volume>16</volume><fpage>477</fpage><pub-id pub-id-type="doi">10.1186/s13023-021-02108-5</pub-id><pub-id pub-id-type="pmid">34794480</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="pediatrrep-17-00056-f001"><label>Figure 1</label><caption><p>Summary representation of interviews results. <bold>Legend:</bold>
<inline-graphic xlink:href="pediatrrep-17-00056-i001.jpg"/>
<bold>Yes</bold>
<inline-graphic xlink:href="pediatrrep-17-00056-i002.jpg"/>
<bold>No</bold>.</p></caption><graphic xlink:href="pediatrrep-17-00056-g001" position="float"/></fig><table-wrap position="float" id="pediatrrep-17-00056-t001"><object-id pub-id-type="pii">pediatrrep-17-00056-t001_Table 1</object-id><label>Table 1</label><caption><p>Sample of interview questions according to themes.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Theme 1: Partners</td><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Are you currently engaged/married?</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Have you ever had partners in the past?</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Are you interested in a couple&#x02019;s relationship?</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Theme 2: Parenthood</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Have you ever thought about the possibility of becoming a parent?</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Do you think your condition could limit your ability to have children?</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Are you afraid that your child might have the same disease as you?</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Theme 3: Pregnancy</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Do you think you have more problems during pregnancy than your peers?</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Do you think special assistance is appropriate for your disease?</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Theme 4: Information</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Would you like to receive more information about fertility and parenting in the case of your disease?</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">By which means would you prefer to be informed?</td></tr></tbody></table></table-wrap><table-wrap position="float" id="pediatrrep-17-00056-t002"><object-id pub-id-type="pii">pediatrrep-17-00056-t002_Table 2</object-id><label>Table 2</label><caption><p>Participants&#x02019; main demographic and disease characteristics.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age (mean &#x000b1; SD)</td><td colspan="2" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">24 &#x000b1; 5.2</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gender (F/M)</td><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">10/13</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of disease</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PKU</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td></tr><tr><td rowspan="5" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UCD </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LCFAOD</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GSD type 1</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Galactosemia</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MSUD</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment options</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diet</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td></tr><tr><td rowspan="3" align="left" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pharmacotherapy</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diet + pharmacotherapy</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Liver transplantation</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Genetic confirmation</td><td colspan="2" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">22/23</td></tr></tbody></table><table-wrap-foot><fn><p><bold>Legend:</bold> PKU, phenylketonuria; UCD, urea cycle disorder; LCFAOD, long-chain fatty acid oxidation disorders; GSD type 1, glycogen storage disease, type 1; MSUD, maple syrup urine disease.</p></fn></table-wrap-foot></table-wrap></floats-group></article>